Basic Information Brief Introduction Semaglutide, developed by Novo Nordisk and sold under the brand names Ozempic, Wegovy and Rybelsus, is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management
Individual suitability varies, and supplements may not be appropriate for everyone
Through a gluten- and dairy-free anti-inflammatory diet, slow-weighted workouts, better sleep, stress management, and key supplements like berberine for PCOS, you can support your gut, your insulin sensitivity, and your hormones the sustainable way
September 17 Product: Novartis Kisqali Indication : Breast cancer Novartis has approximately doubled the eligible patient population for its Kisqali in breast cancer, as the FDA greenlit a label expansion of the drug, in combination with an aromatase inhibitor, for earlier stages of the disease
Introduction Concerns about thyroid cancer with glucagon-like peptide 1 (GLP1) receptor agonist use were first raised in the premarketing phase after studies showed increased rates of thyroid C cell tumours in rodents.1 While the relevance of these findings to humans is not known, in the United States, product labels of GLP1 receptor agonists include boxed warnings about thyroid cancer and these drugs are contraindicated in patients with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2